Details for Patent: 10,702,508
✉ Email this page to a colleague
Which drugs does patent 10,702,508 protect, and when does it expire?
Patent 10,702,508 protects ERLEADA and is included in one NDA.
This patent has eighteen patent family members in sixteen countries.
Summary for Patent: 10,702,508
| Title: | Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer |
| Abstract: | Described herein are methods of treating non-metastatic castrate-resistant prostate cancer using an approved drug product comprising apalutamide, enzalutamide or darolutamide. Also described here are drug products containing apalutamide enzalutamide or darolutamide, and methods of selling or offering for sale an anti-androgen drug product. |
| Inventor(s): | Molina; Arturo (Los Altos Hills, CA) |
| Assignee: | Aragon Pharmaceuticals, Inc. (San Diego, CA) |
| Application Number: | 15/967,452 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 10,702,508
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Janssen Biotech | ERLEADA | apalutamide | TABLET;ORAL | 210951-001 | Feb 14, 2018 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT IN COMBINATION WITH ANDROGEN DEPRIVATION THERAPY OF NON-METASTATIC, CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC) THAT IMPROVES METASTASIS FREE SURVIVAL | ⤷ Try a Trial | ||||
| Janssen Biotech | ERLEADA | apalutamide | TABLET;ORAL | 210951-002 | Feb 17, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT IN COMBINATION WITH ANDROGEN DEPRIVATION THERAPY OF NON-METASTATIC, CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC) THAT IMPROVES METASTASIS FREE SURVIVAL | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,702,508
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 111851 | ⤷ Try a Trial | |||
| Australia | 2018351714 | ⤷ Try a Trial | |||
| Brazil | 112020007439 | ⤷ Try a Trial | |||
| Canada | 3079135 | ⤷ Try a Trial | |||
| China | 111479560 | ⤷ Try a Trial | |||
| Eurasian Patent Organization | 202090960 | ⤷ Try a Trial | |||
| European Patent Office | 3697398 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
